Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-24-073767

Options or other derivatives

  • General Counsel, Corporate Sec acquired 241,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Bryan E. General Counsel, Corporate Sec 2024-06-13 Grant or award · Stock Option (right to buy) +241,650 241,650 D: show line 1 in the form
Loading xslF345X05/ownership.xml…